xue-feng bai
The Ohio State University
Columbus, United States
Review Editor
Cancer Immunity and Immunotherapy
The Ohio State University
Columbus, United States
Review Editor
Cancer Immunity and Immunotherapy
Zhejiang University
Hangzhou, China
Review Editor
Cancer Immunity and Immunotherapy
Department of Clinical Immunology, Jagiellonian University Medical College
Krakow, Poland
Review Editor
Cancer Immunity and Immunotherapy
Case Medical Center, School of Medicine, Case Western Reserve University
Cleveland, United States
Review Editor
Cancer Immunity and Immunotherapy
Department of Probability and Statistics, Alfred Renyi Institute of Mathematics
Budapest, Hungary
Review Editor
Cancer Immunity and Immunotherapy
Institut National de la Santé et de la Recherche Médicale (INSERM)
Paris, France
Review Editor
Cancer Immunity and Immunotherapy
Erasmus Medical Center
Rotterdam, Netherlands
Review Editor
Cancer Immunity and Immunotherapy
University Hospital Bonn
Bonn, Germany
Review Editor
Cancer Immunity and Immunotherapy
University Hospital ZĂĽrich
Zurich, Switzerland
Review Editor
Cancer Immunity and Immunotherapy
Galician Advanced Therapies Manufacturing Center, Galaria-Sergas
Santiago de Compostela, Spain
Review Editor
Cancer Immunity and Immunotherapy
Beth Israel Deaconess Medical Center, Harvard Medical School
Boston, United States
Review Editor
Cancer Immunity and Immunotherapy
Novocure (United States)
Portsmouth, United States
Review Editor
Cancer Immunity and Immunotherapy
Miltenyi Biotec
Bergisch Gladbach, Germany
Review Editor
Cancer Immunity and Immunotherapy
University of Massachusetts Medical School
Worcester, United States
Review Editor
Cancer Immunity and Immunotherapy
University of Texas MD Anderson Cancer Center
Houston, United States
Review Editor
Cancer Immunity and Immunotherapy
National Institutes of Health (NIH)
Bethesda, United States
Review Editor
Cancer Immunity and Immunotherapy